Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches
Thromboinflammation has become a topic of key interest in cardiovascular disease and the prevention of diabetes complications because of the interplay between thrombosis and inflammation in diabetes. Specifically, the significant risk of vascular thrombotic disease in diabetes highlights the need fo...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-10-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.122.027071 |
| _version_ | 1797857430198026240 |
|---|---|
| author | Julia S. Gauer Ramzi A. Ajjan Robert A. S. Ariëns |
| author_facet | Julia S. Gauer Ramzi A. Ajjan Robert A. S. Ariëns |
| author_sort | Julia S. Gauer |
| collection | DOAJ |
| description | Thromboinflammation has become a topic of key interest in cardiovascular disease and the prevention of diabetes complications because of the interplay between thrombosis and inflammation in diabetes. Specifically, the significant risk of vascular thrombotic disease in diabetes highlights the need for new and better therapeutic targets to help manage and prevent vascular thrombo‐occlusive disease in this condition. Similarly, the prominent role of inflammation in diabetes has sparked interest in anti‐inflammatory agents to better prevent and control vascular disease. Investigations on the effects of anticoagulation and antiplatelet interventions in patients with diabetes and cardiovascular disease show a potential role for these agents in decreasing morbidity and mortality. Neutrophils and platelets are key players in inflammation and wound‐healing response, respectively. The interaction between neutrophils and platelets is thought to be an important driver of thromboinflammation. Therefore, this review describes the mechanisms involved in platelet–neutrophil interactions that contribute to the development or exacerbation of thromboinflammation in the context of diabetes and its associated comorbidities. The effects observed by the antithrombotic/antidiabetic treatments and physical activity/dietary interventions on attenuating thromboinflammation are discussed. These data suggest that mechanisms involved in platelet–neutrophil interaction, platelet activation/aggregation, and the recruitment of neutrophils have a promising potential to become therapeutic targets to decrease thromboinflammation in patients with diabetes. |
| first_indexed | 2024-04-09T20:56:35Z |
| format | Article |
| id | doaj.art-90b662e53dd74622aa10bc57df47fb4f |
| institution | Directory Open Access Journal |
| issn | 2047-9980 |
| language | English |
| last_indexed | 2024-04-09T20:56:35Z |
| publishDate | 2022-10-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| spelling | doaj.art-90b662e53dd74622aa10bc57df47fb4f2023-03-29T18:35:07ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802022-10-01112010.1161/JAHA.122.027071Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic ApproachesJulia S. Gauer0Ramzi A. Ajjan1Robert A. S. Ariëns2Discovery and Translational Science Department Institute of Cardiovascular and Metabolic Medicine, University of Leeds Leeds United KingdomDiscovery and Translational Science Department Institute of Cardiovascular and Metabolic Medicine, University of Leeds Leeds United KingdomDiscovery and Translational Science Department Institute of Cardiovascular and Metabolic Medicine, University of Leeds Leeds United KingdomThromboinflammation has become a topic of key interest in cardiovascular disease and the prevention of diabetes complications because of the interplay between thrombosis and inflammation in diabetes. Specifically, the significant risk of vascular thrombotic disease in diabetes highlights the need for new and better therapeutic targets to help manage and prevent vascular thrombo‐occlusive disease in this condition. Similarly, the prominent role of inflammation in diabetes has sparked interest in anti‐inflammatory agents to better prevent and control vascular disease. Investigations on the effects of anticoagulation and antiplatelet interventions in patients with diabetes and cardiovascular disease show a potential role for these agents in decreasing morbidity and mortality. Neutrophils and platelets are key players in inflammation and wound‐healing response, respectively. The interaction between neutrophils and platelets is thought to be an important driver of thromboinflammation. Therefore, this review describes the mechanisms involved in platelet–neutrophil interactions that contribute to the development or exacerbation of thromboinflammation in the context of diabetes and its associated comorbidities. The effects observed by the antithrombotic/antidiabetic treatments and physical activity/dietary interventions on attenuating thromboinflammation are discussed. These data suggest that mechanisms involved in platelet–neutrophil interaction, platelet activation/aggregation, and the recruitment of neutrophils have a promising potential to become therapeutic targets to decrease thromboinflammation in patients with diabetes.https://www.ahajournals.org/doi/10.1161/JAHA.122.027071diabetesneutrophilsplateletthromboinflammation |
| spellingShingle | Julia S. Gauer Ramzi A. Ajjan Robert A. S. Ariëns Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease diabetes neutrophils platelet thromboinflammation |
| title | Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches |
| title_full | Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches |
| title_fullStr | Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches |
| title_full_unstemmed | Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches |
| title_short | Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches |
| title_sort | platelet neutrophil interaction and thromboinflammation in diabetes considerations for novel therapeutic approaches |
| topic | diabetes neutrophils platelet thromboinflammation |
| url | https://www.ahajournals.org/doi/10.1161/JAHA.122.027071 |
| work_keys_str_mv | AT juliasgauer plateletneutrophilinteractionandthromboinflammationindiabetesconsiderationsfornoveltherapeuticapproaches AT ramziaajjan plateletneutrophilinteractionandthromboinflammationindiabetesconsiderationsfornoveltherapeuticapproaches AT robertasariens plateletneutrophilinteractionandthromboinflammationindiabetesconsiderationsfornoveltherapeuticapproaches |